Not applicableWithdrawnNCT05738226What this trial is testingEpiCare@Home Validation Study for Focal Onset SeizuresWho this might be right forEpilepsySeizuresSeizures, Focal+1 more Byteflies
Large-scale testing (Phase 3)Study completedNCT01392768What this trial is testingEfficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationWho this might be right forEpilepsyPartial Seizures Ache Laboratorios Farmaceuticos S.A. 126
Not applicableActive Not RecruitingNCT05248269What this trial is testingThermocoagulation in Drug Resistant Focal EpilepsyWho this might be right forEpilepsySeizures, FocalEpilepsy Intractable+1 more State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Post-approval studies (Phase 4)Ended earlyNCT01266291What this trial is testingSabril for Complex Partial Seizures in Adult Tolerability Study (TS) PatientsWho this might be right forComplex Partial Seizures University of Pennsylvania 1
Large-scale testing (Phase 3)Study completedNCT00319501What this trial is testingEfficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.Who this might be right forSeizuresEpilepsies, PartialEpilepsy, Complex Partial+2 more Pfizer 234
Not applicableStudy completedNCT00001666What this trial is testingTranscranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial EpilepsyWho this might be right forPartial EpilepsySeizures National Institute of Neurological Disorders and Stroke (NINDS) 32
Large-scale testing (Phase 3)Study completedNCT00957372What this trial is testingEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial EpilepsyWho this might be right forPartial Epilepsy Bial - Portela C S.A. 253
Testing effectiveness (Phase 2)Study completedNCT01159431What this trial is testingExternal Trigeminal Nerve Stimulation for EpilepsyWho this might be right forEpilepsySeizure Disorders Olive View-UCLA Education & Research Institute 50
Large-scale testing (Phase 3)Study completedNCT01618695What this trial is testingA Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset SeizuresWho this might be right forPartial-onset Seizures Eisai Co., Ltd. 940
Testing effectiveness (Phase 2)Study completedNCT00105040What this trial is testingA 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresWho this might be right forEpilepsy, Partial UCB Pharma 87
Not applicableLooking for participantsNCT04770337What this trial is testingPivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal EpilepsyWho this might be right forRefractory EpilepsyFocal SeizureSeizures, Focal+4 more Neuroelectrics Corporation 190
Testing effectiveness (Phase 2)Looking for participantsNCT07219407What this trial is testingA Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresWho this might be right forFocal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more Rapport Therapeutics Inc. 30
Large-scale testing (Phase 3)Study completedNCT00699972What this trial is testingEvaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial SeizuresWho this might be right forRefractory Partial Seizures Eisai Inc. 390
Testing effectiveness (Phase 2)Study completedNCT01179854What this trial is testingRemegal Different Doses in Patients With Refractory Partial SeizuresWho this might be right forDrug SafetyNormal Drug ToleranceSelf Efficacy Valexfarm 60
Large-scale testing (Phase 3)Study completedNCT00175890What this trial is testingA Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.Who this might be right forEpilepsy, Partial UCB Pharma 116
Not applicableLooking for participantsNCT07012148What this trial is testingOptimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and WearablesWho this might be right forFocal EpilepsyGeneralized SeizureDrug Refractory Epilepsy Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00957684What this trial is testingEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial SeizuresWho this might be right forRefractory Partial Epilepsy Bial - Portela C S.A. 402
Large-scale testing (Phase 3)Ended earlyNCT00372528What this trial is testingAn Open-Label Study Of Pregabalin In Subjects With Refractory Partial SeizuresWho this might be right forEpilepsy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00236691What this trial is testingThe Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.Who this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Large-scale testing (Phase 3)Study completedNCT00292461What this trial is testingEvaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized SeizuresWho this might be right forEpilepsy Eisai Inc. 64